Wellington Partners Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
14
- Investments
-
281
- Portfolio
-
42
- Exits
-
123
Wellington Partners General Information
Description
Founded in 1991, Wellington Partners is a venture capital firm based in Munich, Germany. The firm seeks to invest in the digital health, artificial intelligence, biotechnology, and software sectors.
Contact Information
Website
www.wellington-partners.com
Year Founded
1991
Investor Status
Actively Seeking New Investments
Trade Association
German Venture Capital Association (BVK)
Principles for Responsible Investment (PRI)
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
- Türkenstrasse 5
- 80333 Munich
- Germany
+49 089 0000000
Wellington Partners Investments (281)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| ImCheck Therapeutics | 10-Jun-2022 | Later Stage VC | 00000 | Drug Discovery | Clinical Trials - Phase 2 | 000000 000000 00.0 |
| 000000 0000 | 19-May-2022 | 00000 00000 | 0000 | Clinics/Outpatient Services | Generating Revenue | |
| 000000 | 10-May-2022 | 00000 00000 | 0000 | Other Healthcare Technology Systems | Generating Revenue | |
| 00000000 (00000 00 | 04-May-2022 | 00000 00000 | 0000 | Other Healthcare Technology Systems | Generating Revenue | 000000 000000 00.0 |
| 000000 | 14-Mar-2022 | 00000 00000 | Biotechnology | Generating Revenue | 000000 000000 00.0 | |
| 0000 000000000000 | 05-Oct-2021 | 00000 00000 | 000.00 | Drug Discovery | Pre-Clinical Trials | 000000 00000000000 00 |
| 000000 | 23-Jun-2021 | 00000 00000 | 00000 | Other Devices and Supplies | Generating Revenue | 000000 00000000000 00 |
| 000000 (0000000000 | 22-Apr-2021 | 00000 00000 | 000.00 | Therapeutic Devices | Generating Revenue/Not Profitable | 000000 000000 00.0 |
| UroMems | 06-Apr-2021 | Later Stage VC | 000.00 | Therapeutic Devices | Generating Revenue | 000000 00000000000 00 |
| Adrenomed | 23-Mar-2021 | Later Stage VC | 000.00 | Drug Discovery | Generating Revenue | 000000 00000000000 00 |
Wellington Partners Exits (123)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Paperton | 28-Jul-2022 | Secondary Transaction - Private | |
| 00000000 | 04-Jun-2022 | 000000000000000000 | 00.000 |
| 000000 | 25-May-2022 | 0000000000 | |
| 000000 | 02-May-2022 | 000000000000000000 | |
| 000000000 | 28-Feb-2022 | 000000000000000000 | |
| 000000 | 01-Jan-2022 | 000000000 00000000 | |
| 00000 | 24-Dec-2021 | 000 00 00000000 | |
| 000000 (0000000000 | 21-Oct-2021 | 000 | 000.00 |
| Edge Intelligence (Business/Productivity Software) | 16-Aug-2021 | Merger/Acquisition | |
| EyeEm | 01-Jun-2021 | Buyout/LBO | 0000 |
Wellington Partners Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
Wellington Partners Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Wellington Partners Team (56)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Harald Keller | Chief Financial Officer & Managing Partner | London, United Kingdom | |||
| Ernst Mannheimer | Legal Counsel & Managing Partner | Munich, Germany | |||
| Karl Nägler Ph.D | Managing Partner | 00 | 0 | 0 | Munich, Germany |
| Rainer Strohmenger MD | Managing Partner | 00 | 0 | 0 | Munich, Germany |
| Regina Hodits Ph.D | Managing Partner | 00 | 0 | 0 | London, United Kingdom |
Wellington Partners Co-Investors (175)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| btov Partners | 4 | 0 |
|
|
|
| EQT Life Sciences | 0 | 0 |
|
|
|
| HBM Healthcare Investments | 0 | 0 |
|
|
|
| HBM Partners | 0 | 0 |
|
|
|
| Novo Holdings | 0 | 0 |
|
|